Anne Turnage

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial

Brian Zambrowicz, J Freiman, Phil Brown et al. · Clinical Pharmacology & Therapeutics · 2012 · 239 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Effects of LX4211, a Dual SGLT1/SGLT2 Inhibitor, Plus Sitagliptin on Postprandial Active GLP-1 and Glycemic Control in Type 2 Diabetes

Brian Zambrowicz, Zhi‐Ming Ding, Ike Ogbaa et al. · Clinical Therapeutics · 2013 · 78 citations

Medicine, Endocrinology, Pharmacology +17

Effects of LX4211, a Dual Sodium-Dependent Glucose Cotransporters 1 and 2 Inhibitor, on Postprandial Glucose, Insulin, Glucagon-like Peptide 1, and Peptide Tyrosine Tyrosine in a Dose-Timing Study in Healthy Subjects

Brian Zambrowicz, Ike Ogbaa, Kenny Frazier et al. · Clinical Therapeutics · 2013 · 65 citations

Medicine, Endocrinology, Pharmacology +13

Comparative gender differences in local and systemic concentrations of pro‐inflammatory cytokines in rats with experimental periodontitis

Jennifer Bain, S. Reid Lester, Will Henry et al. · Journal of Periodontal Research · 2009 · 27 citations

Dentistry, Periodontics, Periodontology +12